Search preferences

Type d'article

Etat

  • Tous
  • Neuf
  • Ancien ou d'occasion

Reliure

  • Toutes
  • Couverture rigide
  • Couverture souple

Particularités

  • Edition originale
  • Signé
  • Jaquette
  • Avec images
  • Sans impression à la demande

Pays

Evaluation du vendeur

  • De Bakey Michael E. - Editor; Cullen, Stuart C. - Editor Anesthesia Section

    Edité par The Year Book Publishers, Chicago,, Illinois, 1960

    Vendeur : Don's Book Store, Albuquerque, NM, Etats-Unis

    Evaluation du vendeur : Evaluation 5 étoiles, Learn more about seller ratings

    Contacter le vendeur

    Livre Edition originale

    EUR 21,66

    Autre devise
    EUR 4,91 Frais de port

    Vers Etats-Unis

    Quantité disponible : 1

    Ajouter au panier

    Hard Back. Etat : Very Good. Etat de la jaquette : No Dust Jacket. First Edition. 616 Pages Indexed. Includes a Section on Anesthesia. Previous owner's name stamped on front endpaper. Date Nov 22 1960 is stamped on the back endpaper. No other marks or stamps to this tight, bright book with near flawless interior text pages. The medical literature of the past few years has reflected concern with regard to the problem of hospital-acquired infections, particularly postoperative staphylococcic infections. The concern persists currently, as indicated by the number of articles on the subject contained in this book and, despite the many advances made in preoperative and postoperative management of patients, the incidence of infection appears to be as high today as it was 20 years ago. These observations again emphasize the great importance of the Listerian doctrine and of well-established principles in wound management, for which there are no substitutes-not even antibiotics. A few years ago, there was great enthusiasm about the development of chemotherapeutic agents for the treatment of malignant disease. Because of the many agents being tested each year, it seemed likely that new and effective ones might be forthcoming as rapidly as new antibiotics for the treatment of specific infections. Unfortunately, they have not appeared. Most of the new tested drugs have been relatively ineffective or have been so toxic to the host that their clinical application has not been feasible.